Electro Optic Systems Holdings Ltd (ASX: EOS) shares are taking a breather on Friday following a huge run over the past month.

At the time of writing, the EOS share price is down 5.54% to $10.40 apiece.

The stock opened at $10.82 and traded as high as $11.10 earlier in the session.

But the pullback follows a very strong run over the past few weeks.

Even after today’s fall, EOS shares are still up around 40% over the past month. And if you zoom out a little further, the shares have almost doubled since February this year.

So, are investors simply taking some money off the table, or is there more going on?

What is weighing on EOS shares today?

There doesn’t appear to be any fresh company news behind the drop, so this looks more like some profit-taking after a stellar few weeks.

EOS shares jumped 23% on Tuesday after the company released its half-year result, before adding another 6.2% on Wednesday. They then slipped 2.1% on Thursday and are giving back more ground today.

The rebound has been even more impressive since the end of July. EOS shares closed at just $6.10 on 30 July, meaning the stock has climbed more than 70% from that level in less than a month.

Given how quickly the shares have climbed, it’s easy to see why some investors might be cashing in some gains.

Why did the shares jump this week?

The half-year result gave investors plenty to get excited about.

Revenue from continuing operations surged 283% to $168.8 million, helped by a big increase in activity across its defence systems business. Underlying EBITDA also swung to a $21.6 million profit from a $14.9 million loss a year earlier.

There was still a $33.7 million loss from continuing operations, although that included a $34 million non-cash fair value loss tied to the MARSS acquisition.

The order book was probably one of the biggest numbers in the result. Contracted work reached around $846 million at 30 June, up from just $170 million a year earlier.

Management is now guiding to full-year 2026 revenue of $360 million to $400 million.

If EOS can hit that range, it would deliver record annual revenue and show investors just how quickly the business is growing.

Foolish takeaway

After climbing so fast over the past month, EOS shares could stay volatile in the near term.

I’d keep an eye on the $10 level first, which has become an important area for the shares this year. Above that, Thursday’s intraday high of $11.98 is another level to watch, before the stock runs into its 52-week high of $12.58.

Bell Potter also remains positive after the result, keeping its ‘buy’ rating and $12.60 price target.

That target sits right around the previous high, so the next test is whether EOS can keep winning contracts.

The post EOS shares are sinking 5% today. Is the huge rally running out of steam? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• What is Bell Potter saying about EOS shares after its results?
• 5 things to watch on the ASX 200 on Wednesday
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Morgans has been busy running the ruler over a number of results this week.

Three popular ASX shares that have come under the spotlight are listed below. Does the broker rate them as buys? Let’s find out.

Netwealth Group Ltd (ASX: NWL)

This investment platform provider delivered a result that was largely in line with expectations.

And while fund inflows have started slowly in FY 2027, Morgans remains positive and has upgraded Netwealth shares to a buy rating with a $27.50 price target. It said:

NWL reported FY26 Revenue +21%; EBITDA +18%; and NPAT +16% on pcp, which was largely in line with MorgF / Consensus expectations. Whilst flows momentum 1Q27 to date has seen a slower start, NWL reaffirmed its FY27 Flows guidance of $18-20bn, with the cadence of flows from MS and other sources expected to step up over the course of the year. We make minor changes to our NPAT forecasts of +1% in FY27-29F, overall, this sees our price target unchanged at A$27.50/sh. We move to a BUY rating.

Sigma Healthcare Ltd (ASX: SIG)

Another ASX share that has been upgraded is Chemist Warehouse owner Sigma Healthcare.

Morgans was pleased with the company’s FY 2026 results, which were in line with expectations. In response, the broker has upgraded Sigma Healthcare shares to a buy rating with a $3.19 price target. It explains:

SIG has posted its FY26 result which was in line with our and consensus forecasts. Highlights included EBIT growth of >20%, Australia CW LFL sales were 13.4% (1H 15.0%; 2H: 11.8%), International CW LFL sales of 12.2%. We note the slight moderation in 2H in Australia was driven by a later start to the cold and flu season and cycling a very strong pcp. SIG is targeting double-digit revenue and earnings growth for FY27. 

We have reduced our forecast by ~3.5%, which sees our TP reduce to A$3.19 (was A$3.30). The market has marked the shares down 7% post the FY26 results and possible sell down by some of the founders (up to 4.7% of issued capital). We believe the share price fall is overdone and provides us with an opportunity to move our recommendation to BUY (from ACCUMULATE).

Wesfarmers Ltd (ASX: WES)

Bunnings and Kmart owner Wesfarmers delivered a result that was largely in line with expectations. 

However, it has started FY 2027 slightly softer than expected. Nevertheless, Morgans has retained its accumulate rating with an improved price target of $85.00. It said:

WES’s FY26 result was broadly in line with expectations, although trading in early FY27 was slightly softer, with management also flagging higher capex in FY27. Earnings from Bunnings, Kmart Group and Health were largely in line with expectations, while Officeworks was slightly above our forecasts. WesCEF was modestly weaker than anticipated. Management noted that while consumer demand remains resilient, cost-of-living pressures persist and customers continue to be value-conscious. 

We make minimal changes to FY27-29F group EBIT but decrease underlying NPAT by 1-2% due to higher net interest expense. Despite these changes, our target price rises to $85.00 (from $81.10) as we believe the increased investments WES is making in the near term will drive sustainable growth over the long term. This is particularly evident across its retail businesses (Bunnings, Kmart Group, Officeworks and Priceline), where investment should strengthen customer value propositions in a subdued consumer environment and position the divisions to capture stronger growth when economic conditions improve. ACCUMULATE rating maintained.

The post Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares appeared first on The Motley Fool Australia.

More reading

• 4 ASX shares scoring upgrades in the final week of earnings season
• 3 ASX 200 shares to buy post-results: broker
• Why now is the time to buy low on these ASX healthcare shares with up to 84% upside
• 5 things to watch on the ASX 200 on Friday
• Everything you need to know about the Wesfarmers dividend

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group and Wesfarmers. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I love receiving dividends from my ASX share portfolio. That’s why a significant portion of my portfolio is focused on ASX dividend shares.

I like to own businesses that pay passive income to my bank account, while also delivering long-term capital growth.

All three of the names I’ll highlight each have a weighting of more than 10% in my portfolio. Let’s run through the appeal of each of them.

Washington H. Soul Pattinson and Co. Ltd (ASX: SOL)

This business has been one of my favourites for a very long time and I imagine it will continue to be so for decades to come.

The investment conglomerate has built a diversified portfolio across a range of sectors including resources, energy, financial services, property, retirement living, swimming schools, electrification and so on.

Its investments are themselves growing, while the business can also expand its portfolio with retained earnings each year. It’s this combination that helps the company’s net asset value (NAV) and share price.

Soul Patts has increased its annual dividend per share every year since 1998, which is the best record for longevity on the ASX. Additionally, it has paid a dividend every year in its 120-year-plus history.

I think this business is one of the best options for a combination of long-term capital and passive income growth. The current grossed-up dividend yield is 3.5%, including franking credits.

MFF Capital Investments Ltd (ASX: MFF)

MFF is another leading business for passive income. The company’s regular annual dividend has increased every year for the past several years.

The listed investment company (LIC) invests in high-quality shares that are competitively advantaged (strong economic moats) with compelling growth outlooks.

With an excellent, diversified portfolio, MFF has achieved strong investment returns and this has funded very good dividends.

In FY26, the company grew its annual dividend per share by 23.5% to 21 cents. I expect the business will increase its FY27 annual dividend by 19% to 25 cents per share.

I think it’s a great option to get exposure to impressive global blue-chips as well as strong passive income.

I believe its FY27 grossed-up dividend yield will be 6.7%, including franking credits, at the time of writing.

L1 Long Short Fund Ltd (ASX: LSF)

The third ASX dividend share that’s a major position in my portfolio is this LIC, which uses a mixture of long-term investing and short-selling through ASX shares and international shares to generate strong returns.

The L1 team generally like to look at businesses with low price/earnings (P/E) ratios, solid earnings growth and a good outlook. That generally means avoiding (long-term) investing in tech shares and instead focusing on names in areas like resources, energy and unloved names in other sectors.

L1 Long Short Fund is paying a quarterly dividend to investors and this payout is increasing every quarter, which is a pleasing growth trajectory.

I expect the FY27 annual dividend will grow by at least 11% year-over-year, translating into a potential grossed-up dividend yield of 4.6%, including franking credits.

With the above three ASX dividend shares, I believe my dividend cash flow is on a very good course.

The post Why these 3 top ASX dividend shares are my biggest holdings appeared first on The Motley Fool Australia.

More reading

• How much do I need to retire on $120,000 a year at 55?
• I’d buy 164,557 shares of this ASX stock to aim for $500 a week of passive income
• Why I’d buy this top ASX dividend share for major passive income today
• How much is needed in superannuation to target a $5,500 monthly passive income?
• How ASX dividend growth shares can build lasting income

Motley Fool contributor Tristan Harrison has positions in L1 Long Short Fund, Mff Capital Investments, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Mff Capital Investments and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.